BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Prognosis
7228 results:

  • 1. Prognostic Implications of Small Cell lung cancer Transcriptional Subtyping for CNS Metastases.
    Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
    JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The impact of COVID-19 on the prognosis of deep vein thrombosis following anticoagulation treatment: a two-year single-center retrospective cohort study.
    Wang Q; Wu J; Zhang P; Ma X
    BMC Pulm Med; 2024 Apr; 24(1):208. PubMed ID: 38671424
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
    Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
    Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The value of lung function assessment and Testin expression detection in clinicopathological features and prognosis of NSCLC patients.
    Zhang Y; Wang G; Zhang Q; Wang Q; Luo J; Ling C
    J Cardiothorac Surg; 2024 Apr; 19(1):223. PubMed ID: 38627776
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dichotomous Effects of Glypican-4 on cancer Progression and Its Crosstalk with Oncogenes.
    Chérouvrier Hansson V; Cheng F; Georgolopoulos G; Mani K
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612755
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma.
    Papavassiliou KA; Sofianidi AA; Papavassiliou AG
    J Cell Mol Med; 2024 Apr; 28(8):e18330. PubMed ID: 38606782
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
    Cao XN; Li Z; Wang QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
    [No Abstract]    [Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis analysis of pulmonary sarcomatoid carcinoma].
    Feng XY; Chen MJ; Xu Y; Zhong W; Liu XY; Gao XX; Zhao J; Wang MZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):319-324. PubMed ID: 38599806
    [No Abstract]    [Full Text] [Related]  

  • 11. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metastasis patterns and prognosis in young gastric cancer patients: A propensity score‑matched SEER database analysis.
    Zhang H; Cheng X; Guo W; Zheng C; Zhang Y; Jing X; Qiao H
    PLoS One; 2024; 19(4):e0301834. PubMed ID: 38593111
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
    Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
    BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
    Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
    Li J; Ma X; Xu F; Yan Y; Chen W
    Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic Significance of CONUT Score in Elderly NSCLC.
    Tamura M; Sakai T; Furukawa N; Yamamoto M; Miyazaki R; Okada H
    Ann Thorac Cardiovasc Surg; 2024; 30(1):. PubMed ID: 38569836
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic significance of inflammation scores in malignant mesothelioma.
    Mutlu E; Inanc M
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2340-2350. PubMed ID: 38567597
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II-III NSCLC.
    Jia K; Zhang C; Li F; He B; Xie S; Du J; Feng G
    Aging (Albany NY); 2024 Mar; 16(7):6212-6228. PubMed ID: 38555532
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment.
    Huang X; Wu S; Chen S; Qiu M; Zhao Y; Wei J; He J; Zhao W; Tan L; Su C; Zhou S
    Int Immunopharmacol; 2024 May; 132():111901. PubMed ID: 38554448
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 362.